Search Results - "Mohn, Kristin G.‐I."

Refine Results
  1. 1

    Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment by Ertesvåg, Nina Urke, Sakkestad, Sunniva Todnem, Zhou, Fan, Hoff, Ingrid, Kristiansen, Trygve, Jonassen, Trygve Müller, Follesø, Elisabeth, Brokstad, Karl Albert, Dyrhovden, Ruben, Mohn, Kristin G.-I

    Published in Viruses (01-08-2022)
    “…Background: Persistent fever after SARS-CoV-2 infection in rituximab-treated patients has been reported. Due to reduced sensitivity in conventional sampling…”
    Get full text
    Journal Article
  2. 2

    Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients by Mohn, Kristin G-I, Bredholt, Geir, Zhou, Fan, Madsen, Anders, Onyango, Therese B, Fjelltveit, Elisabeth B, Jalloh, Sarah L, Brokstad, Karl A, Cantoni, Diego, Mayora-Neto, Martin, Temperton, Nigel, Langeland, Nina, Cox, Rebecca J

    Published in PloS one (22-02-2022)
    “…Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 virus, and long-term memory responses determine the risk of re-infection…”
    Get full text
    Journal Article
  3. 3

    Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients by Paramsothy, Abira, Lartey Jalloh, Sarah, Davies, Richard A., Guttormsen, Anne‐Berit, Cox, Rebecca J., Mohn, Kristin G.‐I.

    Published in Scandinavian journal of immunology (01-08-2021)
    “…There is limited knowledge of influenza‐specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune…”
    Get full text
    Journal Article
  4. 4

    Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination by Manenti, Alessandro, Tete, Sarah M, Mohn, Kristin G.-I, Jul-Larsen, Åsne, Gianchecchi, Elena, Montomoli, Emanuele, Brokstad, Karl A, Cox, Rebecca J

    Published in Vaccine (03-01-2017)
    “…Highlights • LAIV3 induced age-related hemagglutination inhibition antibody responses. • IgG1 was the main IgG subclass detected followed by IgG3. •…”
    Get full text
    Journal Article
  5. 5

    Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway by Mohn, Kristin G-I, Cox, Rebecca Jane, Tunheim, Gro, Berdal, Jan Erik, Hauge, Anna Germundsson, Jul-Larsen, Åsne, Peters, Bjoern, Oftung, Fredrik, Jonassen, Christine Monceyron, Mjaaland, Siri

    Published in PloS one (25-11-2015)
    “…Increased understanding of immune responses influencing clinical severity during pandemic influenza infection is important for improved treatment and vaccine…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Immune responses after live attenuated influenza vaccination by Mohn, Kristin G.-I., Smith, Ingrid, Sjursen, Haakon, Cox, Rebecca Jane

    Published in Human vaccines & immunotherapeutics (04-03-2018)
    “…Since 2003 (US) and 2012 (Europe) the live attenuated influenza vaccine (LAIV) has been used as an alternative to the traditional inactivated influenza…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinical Expectations for Better Influenza Virus Vaccines-Perspectives from the Young Investigators' Point of View by Mohn, Kristin G-I, Zhou, Fan

    Published in Vaccines (Basel) (26-05-2018)
    “…The influenza virus is one of a few viruses that is capable of rendering an otherwise healthy person acutly bedridden for several days. This impressive…”
    Get full text
    Journal Article
  10. 10

    Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review by Bansal, Amit, Trieu, Mai-Chi, Mohn, Kristin G I, Cox, Rebecca Jane

    Published in Frontiers in immunology (06-10-2021)
    “…Annual influenza vaccination is often recommended for pregnant women and young children to reduce the risk of severe influenza. However, most studies…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children by Mohn, Kristin G.-I., Bredholt, Geir, Brokstad, Karl A., Pathirana, Rishi D., Aarstad, Hans J., Tøndel, Camilla, Cox, Rebecca J.

    Published in The Journal of infectious diseases (15-05-2015)
    “…Background. The live attenuated influenza vaccine (LAIV) is the preferred vaccine for children, but the mechanisms behind protective immune responses are…”
    Get full text
    Journal Article
  13. 13

    Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination by Islam, Shahinul, Zhou, Fan, Lartey, Sarah, Mohn, Kristin G. I., Krammer, Florian, Cox, Rebecca Jane, Brokstad, Karl Albert

    Published in Scandinavian journal of immunology (01-10-2019)
    “…Influenza virus is a major respiratory pathogen, and vaccination is the main method of prophylaxis. In 2012, the trivalent live attenuated influenza vaccine…”
    Get full text
    Journal Article
  14. 14

    Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine by Hoen, Lukas, Lartey, Sarah, Zhou, Fan, Pathirana, Rishi D, Krammer, Florian, Mohn, Kristin G-I, Cox, Rebecca J, Brokstad, Karl A

    Published in Vaccines (Basel) (01-08-2024)
    “…Live attenuated influenza vaccines (LAIV) typically induce a poor hemagglutination inhibition (HI) response, which is the standard correlate of protection for…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination by Mohn, Kristin G. I., Zhou, Fan, Brokstad, Karl A., Sridhar, Saranya, Cox, Rebecca J.

    Published in The Journal of infectious diseases (15-05-2017)
    “…Background. Live attenuated influenza vaccines (LAIVs) stimulate a multifaceted immune response including cellular immunity, which may provide protection…”
    Get full text
    Journal Article
  19. 19

    Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study by Fjelltveit, Elisabeth B., Cox, Rebecca Jane, Kittang, Bård Reiakvam, Blomberg, Bjørn, Buanes, Eirik A., Langeland, Nina, Mohn, Kristin G.-I.

    Published in Infectious diseases (London, England) (01-02-2022)
    “…COVID-19 patients are extensively treated with antibiotics despite few bacterial complications. We aimed to study antibiotic use in hospitalized COVID-19…”
    Get full text
    Journal Article
  20. 20

    Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection by Zhou, Fan, Vahokoski, Juha, Langeland, Nina, Cox, Rebecca J.

    Published in npj vaccines (20-02-2024)
    “…The endemic human coronaviruses (HCoVs) circulate worldwide yet remain understudied and unmitigated. The observation of elevated levels of HCoV reactive…”
    Get full text
    Journal Article